These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20215378)

  • 21. Intravitreal bevacizumab for branch retinal vein occlusion.
    Spandau U; Wickenhäuser A; Rensch F; Jonas J
    Acta Ophthalmol Scand; 2007 Feb; 85(1):118-9. PubMed ID: 17244225
    [No Abstract]   [Full Text] [Related]  

  • 22. [Role of intravitreal bevacizumab for resistant macular edema due to central retinal vein occlusion after failure of intravitreal triamcinolone acetonide].
    Le Moigne O; Duncombe A; Portmann A; Muraine M; Genevois O
    J Fr Ophtalmol; 2012 Nov; 35(9):700-4. PubMed ID: 22925843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in areas of capillary nonperfusion after intravitreal injection of bevacizumab in eyes with branch retinal vein occlusion.
    Terui T; Kondo M; Sugita T; Ito Y; Kondo N; Ota I; Miyake K; Terasaki H
    Retina; 2011 Jun; 31(6):1068-74. PubMed ID: 21451440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central retinal vein occlusion after intense exercise: response to intravitreal bevacizumab.
    Jacobs DJ; Ahmad F; Pathengay A; Flynn HW
    Ophthalmic Surg Lasers Imaging; 2011 Jun; 42 Online():e59-62. PubMed ID: 21707016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive optic nerve collateralization after serial intravitreal ranibizumab injections for central retinal vein occlusion.
    Goldberg N; Freund KB
    Retina; 2013 Feb; 33(2):449-50. PubMed ID: 23190926
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
    Cheng KC; Wu WC; Chen KJ
    Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion.
    Rabena MD; Pieramici DJ; Castellarin AA; Nasir MA; Avery RL
    Retina; 2007; 27(4):419-25. PubMed ID: 17420692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinal artery occlusion following intravitreal anti-VEGF therapy.
    von Hanno T; Kinge B; Fossen K
    Acta Ophthalmol; 2010 Mar; 88(2):263-6. PubMed ID: 19416108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal bevacizumab for retinal vein occlusion and early growth of epiretinal membrane: a possible secondary effect?
    Marticorena J; Romano MR; Heimann H; Stappler T; Gibran K; Groenewald C; Pearce I; Wong D
    Br J Ophthalmol; 2011 Mar; 95(3):391-5. PubMed ID: 20693565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion.
    Pai SA; Shetty R; Vijayan PB; Venkatasubramaniam G; Yadav NK; Shetty BK; Babu RB; Narayana KM
    Am J Ophthalmol; 2007 Apr; 143(4):601-6. PubMed ID: 17306753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in a pair-matched analysis.
    Guthoff R; Meigen T; Hennemann K; Schrader W
    Ophthalmologica; 2010; 224(5):319-24. PubMed ID: 20424494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
    Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
    Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion.
    Hu YJ
    Eye (Lond); 2010 Aug; 24(8):1414; author reply 1414-5. PubMed ID: 20339391
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
    Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
    Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion.
    Russo V; Barone A; Conte E; Prascina F; Stella A; Noci ND
    Retina; 2009 Apr; 29(4):511-5. PubMed ID: 19174717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of central retinal vein occlusion-related macular edema with intravitreal bevacizumab (Avastin): preliminary results.
    Pournaras JA; Nguyen C; Vaudaux JD; Konstantinidis L; Ambresin A; Wolfensberger T
    Klin Monbl Augenheilkd; 2008 May; 225(5):397-400. PubMed ID: 18454380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The treatment of branch retinal vein occlusion with bevacizumab.
    Badalà F
    Curr Opin Ophthalmol; 2008 May; 19(3):234-8. PubMed ID: 18408499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema.
    Chung EJ; Roh MI; Kwon OW; Koh HJ
    Retina; 2008; 28(7):957-63. PubMed ID: 18698297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch.
    Yamashiro K; Tsujikawa A; Miyamoto K; Oh H; Otani A; Tamuara H; Ooto S; Sasahara M; Iwama D; Yoshimura N
    Retina; 2010 Mar; 30(3):485-90. PubMed ID: 19952993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early bevacizumab treatment of central retinal vein occlusion.
    Ferrara DC; Koizumi H; Spaide RF
    Am J Ophthalmol; 2007 Dec; 144(6):864-71. PubMed ID: 17916320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.